JACKSON, Miss. / Jun 15, 2023 / Business Wire / UnitedHealthcare Community Plan of Mississippi has been awarded Health Equity Accreditation status by the National Committee for Quality Assurance (NCQA). This accreditation is granted to organizations that lead the market in providing culturally and linguistically sensitive services, and work to reduce health care disparities.
NCQA is an independent, not-for-profit organization dedicated to assessing and reporting on the quality of managed care plans, managed behavioral health care organizations, preferred provider organizations, new health plans, physician organizations, credentials verification organizations, disease management programs and other health-related programs.
Health Equity Accreditation is a nationally recognized accreditation that purchasers, regulators and consumers can use to distinguish organizations that meet rigorous standards in serving a diverse population by:
“We are pleased to receive this recognition, which recognizes our dedicated contributions, efforts and commitment to reducing disparities and improving health outcomes for the members we serve,” said Dr. Michael Parnell, CEO, UnitedHealthcare Community Plan of Mississippi. “We strongly believe that every individual deserves access to high-quality, person-centered care and we will remain determined to identify opportunities to reduce health inequities and improve care in our communities.”
NCQA’s Health Equity Accreditation evaluates how well an organization complies with standards in the following areas:
Some recent examples of UnitedHealthcare’s contributions to addressing health equity and social determinants of health in Mississippi include:
“The prevalence of racial and ethnic disparities has been a barrier to improving the quality of health care of many Americans for too long,” said NCQA President Margaret E. O’Kane. “Organizations achieving Health Equity Accreditation are leaders in closing this gap, and NCQA commends them for their dedication.”
For more information about NCQA Health Equity Accreditation, visit www.ncqa.org.
About NCQA
NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA Accredits and Certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA's Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in health care. NCQA's website (ncqa.org) contains information to help consumers, employers and others make informed health care choices. NCQA can be found online at ncqa.org, on Twitter @ncqa, on Facebook at facebook.com/NCQA.org/ and on LinkedIn at linkedin.com/company/ncqa.
About UnitedHealthcare
UnitedHealthcare is dedicated to helping people live healthier lives and making the health system work better for everyone by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. In the United States, UnitedHealthcare offers the full spectrum of health benefit programs for individuals, employers, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1.5 million physicians and care professionals, and 7,000 hospitals and other care facilities nationwide. The company also provides health benefits and delivers care to people through owned and operated health care facilities in South America. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified health care company. For more information, visit UnitedHealthcare at www.uhc.com or follow @UHC on Twitter.
Last Trade: | US$529.77 |
Daily Change: | 10.05 1.93 |
Daily Volume: | 4,303,204 |
Market Cap: | US$487.540B |
January 16, 2025 October 15, 2024 July 16, 2024 May 23, 2024 September 12, 2023 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load